Contineum Therapeutics, Inc. (CTNM) Shareholders’ equity 2023–2024
Contineum Therapeutics, Inc. (CTNM) shareholders’ equity at each fiscal year-end, per SEC filings.
$198.1MFY2024 · since FY2023: -$67.9M → $198.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $198.1M | +391.5% |
| FY2023 | -$67.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice